Teva, a pharmaceutical manufacturer launched the Qvar RediHaler (beclomethasone dipropionate HFA) Inhalation Aerosol to treat Asthma. This medication is said to treat the people from age 4 years till 60 years.
The medication Qvar RediHaler is proven to display the same active ingredient that you may find in Qvar Inhalation Aerosol.
You may come across Qvar RediHaler in the form of novel breath-actuated inhaler technology.
Teva will discontinue the sales of Qvar after launching Qvar RediHaler. It will be replaced with Qvar metered-dose inhaler.
It has not been proven to relieve acute bronchospasm. According to Dr. Warner W. (Associate Medical Director of Asthma Associates of Southern California), medical groups stated that nearly 68% of patients avoid their metered-dose inhalers which may lead to uncontrolled symptoms of Asthma.
Qvar RediHaler is available in two strengths as 40 mcg and 80 mcg in 10.6g canisters that contain 120 actuations each. Neither shaking with Qvar RediHaler nor priming is required. It may not be used with a spacer or a volume holding chamber and also, shaking the inhaler with the cap open may cause actuation.
“Qvar RediHaler is the first breath-actuated aerosol inhaled corticosteroid indicated for the condition. Unlike metered-dose inhalers (MDIs), the breath-actuated inhaler does not require hand-breath coordination during inhalation.”
NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.
DISCLAIMER: This content is provided for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physicians with any questions regarding a medical condition and to obtain medical advice and treatment.
Happiness Blooms from Healthy Life 